SUPN
Supernus Pharmaceuticals Inc
Price:  
36.74 
USD
Volume:  
236,515.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SUPN WACC - Weighted Average Cost of Capital

The WACC of Supernus Pharmaceuticals Inc (SUPN) is 5.8%.

The Cost of Equity of Supernus Pharmaceuticals Inc (SUPN) is 8.35%.
The Cost of Debt of Supernus Pharmaceuticals Inc (SUPN) is 4.25%.

Range Selected
Cost of equity 7.10% - 9.60% 8.35%
Tax rate 24.20% - 25.70% 24.95%
Cost of debt 4.00% - 4.50% 4.25%
WACC 5.1% - 6.5% 5.8%
WACC

SUPN WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.71 0.85
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.10% 9.60%
Tax rate 24.20% 25.70%
Debt/Equity ratio 1 1
Cost of debt 4.00% 4.50%
After-tax WACC 5.1% 6.5%
Selected WACC 5.8%